Macrocytic anemia medical therapy: Difference between revisions
Line 47: | Line 47: | ||
*** Oral regimen | *** Oral regimen | ||
**** Preferred regimen (1): [[Cyanocobalamin Injection|Cyanocobalamin]] 350-500μg PO q24h<ref name="pmid28392254" /> | **** Preferred regimen (1): [[Cyanocobalamin Injection|Cyanocobalamin]] 350-500μg PO q24h<ref name="pmid28392254" /> | ||
**** Alternative regimen (1): [[Cyanocobalamin Injection|Cyanocobalamin]] 1000-2000 μg PO q24h<ref name="pmid23301732" /> ''' | **** Alternative regimen (1): [[Cyanocobalamin Injection|Cyanocobalamin]] 1000-2000 μg PO q24h<ref name="pmid23301732" /> | ||
* '''Folate deficiency''' | |||
** Parenteral regimen | ** Parenteral regimen | ||
*** Preferred regimen (1): [[ | *** Preferred regimen (1):[[Folic Acid]] 0.4-1 mg IV q 24h and maintenance doswe 0.4 mg q 24h<ref>{{cite book | last = DiPiro | first = Joseph | title = Pharmacotherapy : a pathophysiologic approach | publisher = McGraw-Hill Education | location = New York | year = 2017 | isbn = 9781259587481 }}</ref> | ||
** Oral regimen | ** Oral regimen | ||
*** Preferred regimen (1): | *** Preferred regimen (1): [[Folic Acid]] 1-5 mg PO q 24h<ref>{{cite book | last = DiPiro | first = Joseph | title = Pharmacotherapy : a pathophysiologic approach | publisher = McGraw-Hill Education | location = New York | year = 2017 | isbn = 9781259587481 }}</ref> | ||
* | *** Alternative regimen (1): [[Folic Acid]] 1-15 mg PO q 24h<ref>{{cite book | last = DiPiro | first = Joseph | title = Pharmacotherapy : a pathophysiologic approach | publisher = McGraw-Hill Education | location = New York | year = 2017 | isbn = 9781259587481 }}</ref> | ||
* [[ | |||
* [LDH]] falls in 2 days. [[Hypokalemia]] requiring replacement can occur in the acute phase as new cells are being generated rapidly. | * [LDH]] falls in 2 days. [[Hypokalemia]] requiring replacement can occur in the acute phase as new cells are being generated rapidly. | ||
* A [[reticulocytosis]] begins in 3-5 days and peaks in 10 days. The HCT will rise within 10days. If it does not, suspect another disorder. Hypersegmented PMNs disappear in 10-14 days. | * A [[reticulocytosis]] begins in 3-5 days and peaks in 10 days. The HCT will rise within 10days. If it does not, suspect another disorder. Hypersegmented PMNs disappear in 10-14 days. |
Revision as of 21:39, 24 August 2018
Macrocytic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Macrocytic anemia medical therapy On the Web |
American Roentgen Ray Society Images of Macrocytic anemia medical therapy |
Risk calculators and risk factors for Macrocytic anemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
[Therapy] is recommended among all patients who develop [disease name].
OR
Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
OR
Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
OR
Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
OR
Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
Medical Therapy
- Pharmacologic medical therapy is recommended among patients which don't improve on dietary measures.[1]
- Vitamin B12 deficiency
- Mild
- Parenteral regimen
- Preferred regimen (1): Cyanocobalamin 1000 μg IM q24h for 7 days, then q weekly for 4-8 weeks [1]
- Oral regimen
- Preferred regimen (1): Cyanocobalamin 500-1000 μg PO q24h[1]
- Parenteral regimen
- Severe
- Parenteral regimen
- Preferred regimen (1):Cyanocobalamin 1000 μg IM q24h for 7 days, then q weekly for 4-8 weeks [1]
- Oral regimen
- Preferred regimen (1): Cyanocobalamin1000-2000 μg PO q24h[1]
- Parenteral regimen
- Pernicious anemia
- Parenteral regimen
- Preferred regimen (1):Cyanocobalamin 1000 μg IM q24h for 7 days, then q weekly for 4-8 weeks [1]
- Alternative regimen (1): Cyanocobalamin 100-1000 μg IM q24h for 1-2 weeks and then 1-3 months[2]
- Oral regimen
- Preferred regimen (1): Cyanocobalamin1000-2000 μg PO q24h[1]
- Parenteral regimen
- Gastric bypass
- Parenteral regimen
- Preferred regimen (1):Cyanocobalamin 1000 μg IM or SQ q monthly[3]
- Alternative regimen (1): Cyanocobalamin 1000 μg IM q monthly[1]
- Oral regimen
- Preferred regimen (1): Cyanocobalamin 350-500μg PO q24h[3]
- Alternative regimen (1): Cyanocobalamin 1000-2000 μg PO q24h[1]
- Parenteral regimen
- Mild
- Folate deficiency
- Parenteral regimen
- Preferred regimen (1):Folic Acid 0.4-1 mg IV q 24h and maintenance doswe 0.4 mg q 24h[4]
- Oral regimen
- Preferred regimen (1): Folic Acid 1-5 mg PO q 24h[5]
- Alternative regimen (1): Folic Acid 1-15 mg PO q 24h[6]
- Parenteral regimen
- [LDH]] falls in 2 days. Hypokalemia requiring replacement can occur in the acute phase as new cells are being generated rapidly.
- A reticulocytosis begins in 3-5 days and peaks in 10 days. The HCT will rise within 10days. If it does not, suspect another disorder. Hypersegmented PMNs disappear in 10-14 days.
- Neurologic abnormalities may take up to 6 months to resolve if ever. The longer the disease has been present, the worse is the prognosis for recovery.
- Persons with PA have a 2x risk of gastric CA (in some studies). Screen for occult blood.
Contraindicated medications
Macrocytic Anemia is considered an absolute contraindication to the use of the following medications:
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Stabler SP (January 2013). "Clinical practice. Vitamin B12 deficiency". N. Engl. J. Med. 368 (2): 149–60. doi:10.1056/NEJMcp1113996. PMID 23301732.
- ↑ Oh R, Brown DL (March 2003). "Vitamin B12 deficiency". Am Fam Physician. 67 (5): 979–86. PMID 12643357.
- ↑ 3.0 3.1 Parrott J, Frank L, Rabena R, Craggs-Dino L, Isom KA, Greiman L (May 2017). "American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients". Surg Obes Relat Dis. 13 (5): 727–741. doi:10.1016/j.soard.2016.12.018. PMID 28392254.
- ↑ DiPiro, Joseph (2017). Pharmacotherapy : a pathophysiologic approach. New York: McGraw-Hill Education. ISBN 9781259587481.
- ↑ DiPiro, Joseph (2017). Pharmacotherapy : a pathophysiologic approach. New York: McGraw-Hill Education. ISBN 9781259587481.
- ↑ DiPiro, Joseph (2017). Pharmacotherapy : a pathophysiologic approach. New York: McGraw-Hill Education. ISBN 9781259587481.